|Videos|December 23, 2019

Best Practices for the Treatment of Hemophilia

Episodes in this series

Now Playing

EP. 1 Best Practices for the Treatment of Hemophilia

EP. 2 Overview, Diagnosis, and Complications of Hemophilia

EP. 3 Practice Pearl 1: Determining Severity and Goals of Therapy

EP. 4 Practice Pearl 1: Identifying Patients and Regimens for Prophylaxis

EP. 5 Practice Pearl 2: Determining the Role of Factor VIII

EP. 6 Practice Pearl 2: Patient Factors for Other Treatments

EP. 7 Practice Pearl 2: Administration Concerns, Costs, and Risks

EP. 8 Practice Pearl 3: Procedure for Transitioning and Patient Education

EP. 9 Practice Pearl 3: Reviewing the Dispensing Process

EP. 10 Practice Pearl 3: Complications and Pain Management With Hemophilia

EP. 11 Practice Pearl 4: Calculating Doses for Individualized Treatment

EP. 12 Practice Pearl 4: Dosing Complications and Various Dosage Vials

EP. 13 Practice Pearl 4: Challenges in Treatments and Final Thoughts

EP. 14 Hemophilia Practice Pearls Takeaways: Determining Goals of Therapy

EP. 15 Hemophilia Practice Pearls: Best Practices, Treatment Costs

Luigi Brunetti, PharmD, MPH, BCPS, BCGP, associate professor, Rutgers University Ernest Mario School of Pharmacy, and Robert Wood Johnson University Hospital, Somerset, New Jersey, moderates a discussion on best practices for hemophilia treatment. He is joined by Robert F Sidonio, Jr, MD, medical director of Hemophilia, Aflac Cancer and Blood Disorders Center, Children’s Healthcare of Atlanta, and assistant professor of pediatrics,Emory University School of Medicine, Atlanta, Georgia; and Giles W. Slocum, Pharm.D., BCCCP, clinical pharmacy specialist, Emergency Medicine, Rush University Medical Center in Illinois.

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Best Practices for the Treatment of Hemophilia

Episodes in this series

EP. 1 Best Practices for the Treatment of Hemophilia

EP. 2 Overview, Diagnosis, and Complications of Hemophilia

EP. 3 Practice Pearl 1: Determining Severity and Goals of Therapy

EP. 4 Practice Pearl 1: Identifying Patients and Regimens for Prophylaxis

EP. 5 Practice Pearl 2: Determining the Role of Factor VIII

EP. 6 Practice Pearl 2: Patient Factors for Other Treatments

EP. 7 Practice Pearl 2: Administration Concerns, Costs, and Risks

EP. 8 Practice Pearl 3: Procedure for Transitioning and Patient Education

EP. 9 Practice Pearl 3: Reviewing the Dispensing Process

EP. 10 Practice Pearl 3: Complications and Pain Management With Hemophilia

EP. 11 Practice Pearl 4: Calculating Doses for Individualized Treatment

EP. 12 Practice Pearl 4: Dosing Complications and Various Dosage Vials

EP. 13 Practice Pearl 4: Challenges in Treatments and Final Thoughts

EP. 14 Hemophilia Practice Pearls Takeaways: Determining Goals of Therapy

EP. 15 Hemophilia Practice Pearls: Best Practices, Treatment Costs

Related Content

Pharmacy’s Role in Implementing Pafolacianine for Fluorescence-Guided Lung Cancer Surgery

Half-Life, High Cost, High Stakes: Radiopharmaceuticals in Oncology Practice

Q&A: Machine Learning Update Makes Accurate LDL-C Easier for Labs

Cervical Cancer Screening and HPV Self-Collection: What Pharmacists Want Patients to Know

Suzetrigine Nears 1 Million Prescriptions as Reimbursed Access Expands for Nonopioid Acute Pain Treatment

Latest CME

Redefining Complement-Mediated Kidney Disease: The Latest in Diagnosis and Treatment

Infectious Disease Day of Education 2026

Clinical Panel Debate: CAR T-Cell Therapy vs Bispecific Antibodies

The Pharmacist's Role in Palliative and End of Life Symptom Management

Navigating the Legal Landscape of Telehealth: Updates and Implications for Pharmacists and Technicians

NEIAP Conference 2026

Lymphoma Day of Education 2026

Infectious Disease Day of Education 2026

Advancing Treatment Strategies in Extensive-Stage Small Cell Lung Cancer: Enhancing Pharmacist Competence in Therapy Selection, Administration, and Adverse Event Management

From Payload to Patient: Managing Toxicities of Antibody-Drug Conjugates Directed at HER2 and TROP2

Advancing the Idiopathic Pulmonary Fibrosis Treatment Landscape: What’s Next in Care

Sugar, We’re Going Down: Navigating Glycemic Control in the Era of PI3K/AKT Inhibition for Breast Cancer

Hat Trick for Hypertension: Strategies to Improve Outcomes With Single-Pill Combinations

Advancing HER2-Driven Cancer Care, Biomarker Testing, and Pharmacist Innovation

New Drug Approvals for 2025 (Pharmacy Technician Credit)

Innovations in Hidradenitis Suppurativa Treatment: Navigating the Evolving Landscape

Redefining Care in Polycythemia Vera and Essential Thrombocythemia: Emerging Evidence, Evolving Strategies, and the Pharmacist’s Role

The Educated Pharmacist - Weighing In: Translating Evidence to Practice — A Multidisciplinary Analysis of Obesity Pharmacotherapy Implementation and Team-Based Care

Innovations in Narcolepsy Treatment: Emerging Targets and Implications for Managed Care

Evolving Treatment Options in Plaque Psoriasis: Implications of Emerging TYK2 Inhibitors for Managed Care

New Treatments in Systemic Lupus Erythematosus to Advance Care: A Managed Care Focus on Nephritis

Looking at Patient-Centered Care in Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema Through a Value-Based Lens

NEIAP 2026 Annual Forum

PBMI 2026

Addressing Gaps in Care for the Rapid and Long-Term Management of Hyperkalemia With Novel Oral Potassium Binding Agents: Insights for Managed Care Professionals

An American Journal of Managed Care Forum: Bridging Evidence and Access in Advanced Small Cell Lung Cancer

Continuing the Conversation: Pharmacist Interventions to Optimize T2D Care and Break Through Clinical Inertia

New Oncology Therapy Approvals for 2025 (Pharmacist Credit)

The Pharmacist's Role in Palliative and End of Life Symptom Management (Pharmacy Technician Credit)

Exploring Immunotherapy Strategies in Endometrial Cancer

Managing Steroid-Refractory Chronic Graft-versus-Host Disease With Novel Therapies: Opportunities for Pharmacist-Led Interventions

Best Practice Approaches for Understanding Chronic Obstructive Pulmonary Disease and Precision Medicine Treatment

Collaborative Practice Agreement Implementation and Adherence: A Practical Roadmap for Oncology Pharmacists

HER2-Positive Metastatic Breast Cancer: A Managed Care Perspective on Emerging Therapies and Clinical Data

Enhancing The Role of Oncology Pharmacists in Multidisciplinary Myeloproliferative Neoplasm Care

Advancing Patient Safety: Strategies to Address Safety Risks and Adherence Barriers to Optimize Outcomes for Patients on Injectable Therapies

The Educated Pharmacist: Overcoming Clinical Inertia—An Interactive Case Workshop for Optimizing Insulin Use

Artificial Intelligence in Pharmacy Practice: Validated Tools, Real-World Applications, and Emerging Innovations (Pharmacy Technician Credit)

Advancing Chronic Kidney Disease Detection and Cardiovascular Risk Reduction in Complex Patients

Optimizing Bispecific Antibody Therapy in Relapsed/Refractory Lymphomas: A Practical Guide for Pharmacists

Two Targets, One Mission: Optimizing Bispecific Antibody Use in Non-Hodgkin Lymphoma

Pharmacogenomics in Practice: Enhancing Patient Care Through Genetic Insights

Navigating the Complexities of Personalized Prostate Cancer Care: Insights for Oncology Managed Care

Lymphoma Day of Education 2026

Addressing Vaccine Hesitancy in Infectious Disease Prevention

Targeting the Root of Autoimmunity in Generalized Myasthenia Gravis: Pharmacist Strategies for Integrating FcRn Therapies Into Specialty Practice

IL-23 Inhibitors in Psoriasis: Optimizing Access and Patient Outcomes Across Integrated Systems

Utilizing VMAT-2 Inhibitors for the Management of Tardive Dyskinesia: The Role of Long-Term Care Pharmacists

The Expanding Therapeutic Landscape in IgA Nephropathy: Translating New Clinical Evidence and Updated Guidelines Into Managed Care Strategies

From Guidelines to Action: Implementing Pneumococcal Vaccine ACIP Recommendations in Long-Term Care Settings

Effective Strategies to Manage Hyperglycemia When Treating with PI3K and AKT Inhibitors

Multidisciplinary Insights and Strategies for Patients Treated With PI3K and AKT Inhibitors to Prevent Hyperglycemia

Navigating Advanced Prostate Cancer Treatment: Optimizing Novel Therapeutic Strategies for Managed Care Pharmacists

Innovations in Retinal Therapies: A Managed Care Perspective on Anti-VEGF Advancements

Cardiorenal Protection With SGLT2 Inhibitors: Perspectives for Managed Care

Bridging Innovation and Access in HR-Positive/HER2-Negative Metastatic Breast Cancer: Implications for Managed Care